MedMira CEO Invited to Speak on Innovation and Technology at the United Nations Conference on Trade and Development

    




 HALIFAX, April 17, 2012 /CNW/ - MedMira Inc., (MedMira) , a  developer of rapid diagnostic technology and solutions, annoud today  that Company co-founder and CEO, Hermes Chan, will be speaking at the  Innovation and Technology Day (ITD) in Doha, Qatar on April 24, 2012.   ITD, an open forum for technology pioneers, entrepreneurs, policy  makers, and experts, designed to facilitate the dialogue and action on  key issues related to innovation, technology and development, is a  joint initiative of the United Nations Conference on Trade and  Development and the Qatar Foundation. 

 Mr. Chan will take the stage to speak about the inspiration behind  MedMira and his experiences in creating and commercializing Company's  patented rapid diagnostics technology platform and diagnostic  applications as well as the impact of these innovations on both  healthcare and economic growth in developing countries.  The audience  will be composed of members of Diplomatic Delegations and Government  officials from many countries as well as individuals from the network  of universities and research centers of the Qatar Foundation. 

 "It is a privilege to be invited to speak at UNCTAD XIII about  innovation, something which I am very passionate about and which is at  the heart of everything we have done and continue to accomplish at  MedMira," said Hermes Chan, CEO, MedMira.  "Sharing the MedMira vision  in this world class international forum is a great honor and an  exciting opportunity to build key relationships with organizations such  as UNCTAD, the Qatar Foundation, and other agencies working to further  economic sustainability in developing countries through innovation and  technology." 

 ITD is part of the thirteenth session of the United Nations Conference  on Trade and Development (UNCTAD XIII) taking place April 21-26, 2012  in Doha, Qatar.  Within the United Nations system, UNCTAD is the focal  point for the integrated treatment of trade and development and the  interrelated issues in the areas of finance, technology, investment,  and sustainable development. To learn more visit www.innotechday.org. 

 About MedMira 

 MedMira is a leading developer and manufacturer of flow-through rapid  diagnostics and technologies. The company's tests provide hospitals,  labs, clinics and individuals with reliable, rapid diagnosis for  diseases such as HIV and hepatitis C in just three minutes. The  company's tests are sold under the Reveal®, Multiplo™ and Miriad brands  in global markets. MedMira's rapid flow-through HIV test is the only  one in the world to achieve regulatory approvals in Canada, the United  States, China and the European Union. MedMira's corporate offices and  manufacturing facilities are located in Halifax, Nova Scotia, Canada.  For more information visit MedMira's website at www.medmira.com. 

 This news release contains forward-looking statements, which involve  risk and uncertainties and reflect the Company's current expectation  regarding future events including statements regarding possible future  growth and new business opportunities.  Actual events could materially  differ from those projected herein and depend on a number of factors  including, but not limited to, changing market conditions, successful  and timely completion of clinical studies, uncertainties related to the  regulatory approval process, establishment of corporate alliances and  other risks detailed from time to time in the company quarterly  filings. 

 Neither TSX Venture Exchange nor its Regulation Services Provider (as  that term is defined in the policies of the TSX Venture Exchange)  accepts responsibility for the adequacy or accuracy of this release. 

MEDMIRA INC.


CONTACT:  Andrea Young, Corporate CommunicationsTel: 902-450-1588Email: [e-mail] 


    

Copyright